TRICS IV: Restrictive versus Liberal Transfusion in Younger Patients Undergoing Cardiac Surgery
An international, multi-centre, randomised controlled trial to assess transfusion thresholds in younger patients undergoing cardiac surgery.
1,440 patients will be enrolled internationally.
Study design: Multi-centre open-label randomised controlled trial (RCT) of a restrictive versus liberal transfusion strategy in higher risk patients ≤65 years of age having cardiac surgery on cardiopulmonary bypass, using a superiority trial design.
Hypothesis: A higher haemoglobin (Hb) concentration for red blood cell (RBC) transfusion (liberal transfusion strategy) will be superior to a restrictive strategy in terms of vital organ function (heart, brain and kidney) and mortality 6 months after cardiac surgery.
Principal Investigator (Canada)
Dr David Mazer, St. Michael’s Hospital (Toronto, ON, Canada)
Principal Investigator (Australia)
Professor David Scott, Department of Critical Care and St Vincent's Hospital, Melbourne
Trial Manager (Australia)
Bhavita Patel, TRICS IV Trial Manager, Department of Critical Care, University of Melbourne
Prof David Scott
Prof Alistair Royse
Dr Raymond Hu
Prof John Fraser
Prof Cyril David Mazer
Dr Nadine Shehata
Prof Paul Bannon
Prof James Isbister
St Vincent's Hospital, Melbourne
St. Michael’s Hospital (Toronto, ON, Canada)
Australian and New Zealand College of Anaesthetists Clinical Trials Network (ANZCA CTN)
MRFF ICTC Grant $869,565 (2021-2024)
School Research Themes
For further information about this research, please contact the research group leader.
Department / Centre
MDHS Research library
Explore by researcher, school, project or topic.